Biotechnology IP & Ethics
One Year Subscription Only Terms
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing firstname.lastname@example.org; or returning the invoice marked 'CANCEL'.
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
Biotechnology: Walking the Tightrope Between IP and Ethics
Biotechnology has become one of the most vital sectors of the economy, responsible for countless breakthroughs in medicine and agriculture. As this area has continued to grow-often sparking controversy along the way-lawyers and policy makers have been forced to play catch up, grappling to understand how intellectual property faces with ethical issues within the context of biotechnology.
Professors Gold and Knoppers, with their combined wealth of expertise and experience in intellectual property policy, biotechnology and ethics, have tackled these issues in Biotechnology IP&; Ethics, a new book from Butterworths. The result is an indispensable guide that provides practitioners context for the multiple biotechnology-related issues they face.
Features and Benefits
Packed with expert commentary from a wide variety of scholars and lawyers working in the intellectual property field, Biotechnology IP&; Ethics fills a gaping need in the market, arming practitioners and policy makers with the tools needed to present better legal arguments and provide more sound advice within this controversial industry, including:
- Expert analysis - in-depth coverage of biotechnology, both within Canada and internationally, including discussions on current controversies, such as stem cell research and access to medicine, where intellectual property can be at odds with ethical concerns
- Single source research - practitioners may now avail, within a single source, opinions and commentary that were previously only accessible from countless academic journal articles and international reports
- Relevant case studies and case law - examples from both practical applications and case law are employed to help illustrate key points for the reader
Providing Context to the Controversy
A forward-looking publication, this book will help readers come to grips with the direction of biotechnology and intellectual property, while understanding the ethical issues currently faced and those still to come. Readers will gain a clearer grasp of a full range of issues, including:
- The application of intellectual property law within biotechnology
- The use of patented inventions such as research tools and DNA sequences by researchers
- How to address ethical concerns through the employment of suitable intellectual property management strategies
- How biotechnology may be able to deal with health and food challenges in developing nations and how biotechnology IP factors into this discussion
- The impact of biotechnology IP and ethical issues on the health care sector
A Perfect Solution For
- IP practitioners and professors - who need to understand how ethical concerns can create major problems when obtaining or licensing intellectual property
- Property practitioners and professors - who must deal with a biotechnology sector that not only focuses on patents and other intellectual property, but also rights in cells which fall under the rubric of property law
- Ethics departments and review committees - who seek the requisite background information on IP and an understanding of how ethics and biotechnology intersect in relation to IP
- Health law practitioners - who are dealing with issues such as access to medicine and providing services at a time when an increasing amount of health related innovations are covered by intellectual property
Table of contents
Part 1: "Situating Bioethics": Background and History
Introduction to Intellectual Property Rights and to
Intellectual Property and Ethics
Part 2: "Of Patients and Patents": Commercialization
IP Rights & Biotechnology
Proposed Solutions to Shape IP Rights Over Biotechnology
Part 3: "Healthcare and Development Challenges": Affordability and Access